Previous 10 | Next 10 |
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Stifel 3 rd Annual CNS Day on Thursday, April 1, 2021 at 11:00 am ET. A live audio webcast of the presentation will be ...
– Alnylam to Share Additional Data From its RNAi Product Portfolio Including ATTR Amyloidosis and Acute Hepatic Porphyria – –Company to Host Conference Call April 19 th at 4:00 pm ET to Discuss HELIOS-A Results – Alnylam Pharmaceutic...
– New Strategic Framework Highlights Alnylam’s Approach to Corporate Responsibility, Establishing the Foundation for Continuous Tracking of Initiatives and Progress — Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company...
Company to Administer First FDA-Approved GalNAc-Conjugate RNA Therapeutic Soleo Health , an innovative leader and national provider of complex specialty pharmacy and infusion services, announced today it has joined the treatment center directory for GIVLAARI ® ...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the 10 th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 11:20 am ET. A live audio webca...
Citi analyst Joel Beatty has downgraded shares of Alnylam (ALNY) from buy/high risk to neutral/high risk amid upside threats.Beatty, however, increased his price target $5 to $175.He cities competitor threats to Alnylam's hereditary ATTR (amyloidosis) business from Eidos Therapeutics' (EIDX) ...
The following slide deck was published by Alnylam Pharmaceuticals, Inc. in conjunction with their 2020 Q4 earnings call. For further details see: Alnylam Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation
Alnylam Pharmaceuticals, Inc (ALNY) Q4 2020 Earnings Conference Call February 11, 2021, 8:30 AM ET Company Participants Christine Lindenboom - Senior Vice President of Investor Relations & Corporate Communications John Maraganore - Chief Executive Officer Tolga Tanguler - Chief Commercial...
Image source: The Motley Fool. Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) Q4 2020 Earnings Call Feb 11, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Alnylam Pharmaceuticals Inc (ALNY) Q4 2020 Earnings Call Transc...
Alnylam Pharmaceuticals ([[ALNY]] -0.4%) reports Q4 total revenues of $163.56M, an increase 128.2% Y/Y, beats consensus by $15.85M.Combined net product revenues were $112.8M in Q4, representing 102% growth from last year, the strong growth primarily resulted from an incre...
News, Short Squeeze, Breakout and More Instantly...
Alnylam Pharmaceuticals Inc. Company Name:
ALNY Stock Symbol:
NASDAQ Market:
Alnylam Pharmaceuticals Inc. Website:
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the second quarter ending June 30, 2024 on Thursday, August 1, 2024, before the U.S. financial markets open. Management will provide an update on th...
2024-06-29 16:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...